CRELD1 antibody
Principal name
CRELD1 antibody
Alternative names for CRELD1 antibody
CIRRIN, Cysteine-rich with EGF-like domain protein 1
Ncbi ID
9606, NP_001070883, NP_001026887.1, NM_001031717, NP_001026887, NP_598691.1, NM_001024783, NM_001077415, NM_015513
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P), Enzyme Immunoassay (E)
Background of CRELD1 antibody
- Kit Component:
- - KN303818G1, Creld1 gRNA vector 1 in pCas-Guide vector
- KN303818G2, Creld1 gRNA vector 2 in pCas-Guide vector
- KN303818D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Human kidney; CRELD1 antibody - C-terminal region (ARP45004_T100) in Human kidney cells using Immunohistochemistry
Human HepG2; WB Suggested Anti-CRELD1 Antibody Titration: 5.0ug/ml. Positive Control: HepG2 cell lysate; CRELD1 antibody - C-terminal region (ARP45004_T100) in Human HepG2 cells using Western Blot
Host: Rabbit; Target Name: Creld1; Sample Tissue: Mouse Lung lysates; Antibody Dilution: 1.0 ug/ml
WB Suggested Anti-CRELD1 Antibody Titration: 5.0 ug/ml; Positive Control: HepG2 cell lysate
Human kidney
Gel: 10%SDS-PAGE, Lysate: 40 ug, Lane 1-2: Mouse bladder tissue, 293T cells, Primary antibody: (CRELD1 Antibody) at dilution 1/930, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 5 minutes
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using (CRELD1 Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human brain tissue using (CRELD1 Antibody) at dilution 1/40, on the right is treated with synthetic peptide. (Original magnification: ×200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA351100 | CRELD1 antibody |
||||||
| Rabbit Polyclonal Anti-CRELD1 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +2 additional images |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP301774 | CRELD1 (transcript variant 1) |
||||
| Recombinant protein of human cysteine-rich with EGF-like domains 1 (CRELD1), transcript variant 1 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY422168 | CRELD1 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Rat Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RR213535L2V | Lenti ORF particles, Creld1 (GFP-tagged ORF) - Rat cysteine-rich with EGF-like domains 1 (Creld1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| RR213535L1V | Lenti ORF particles, Creld1 (Myc-DDK-tagged ORF) - Rat cysteine-rich with EGF-like domains 1 (Creld1), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||